Header Logo

Connection

James Mulshine to Organoplatinum Compounds

Back to Details
This is a "connection" page, showing publications James Mulshine has written about Organoplatinum Compounds.
James Mulshine
Connection Strength
0.090
Organoplatinum Compounds
  1. A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity. Am J Clin Oncol. 1990 Aug; 13(4):285-9.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.